Exercise Training as Prophylactic Strategy in the Management of Neutropenia during Chemotherapy

Tim Schauer, Pernille Hojman, Julie Gehl, Jesper Frank Christensen*

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftReviewForskningpeer review


Chemotherapy-induced immune-suppression is a common, but potential detrimental, adverse reaction in patients undergoing treatment for cancer and strategies with capacity to boost the immune cell populations are needed. Physical exercise training is a potent regulator of immune cell viability and function and may serve as a viable, non-pharmacological prophylactic strategy in addition to the current pharmacological management by, for example, granulocyte-colony stimulating factor (G-CSF). Here, we review the mechanistic evidence linking exercise training to haematopoietic function and subsequent possible amelioration of chemotherapy-related neutropenia. First, we briefly describe neutrophil regulation and management of neutropenia in cancer patients. Second, we summarize the effect of acute and chronic exercise training on neutrophils and their progenitors, and finally, we outline the current clinical evidence of exercise interventions in ongoing anti-cancer treatment in regard to neutropenia incidence, treatment tolerance and related outcomes. LINKED ARTICLES: This article is part of a themed issue on New avenues in cancer prevention and treatment (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.12/issuetoc.

Sider (fra-til)2925-2937
Antal sider13
TidsskriftBritish Journal of Pharmacology
Udgave nummer12
Tidlig onlinedato25 maj 2020
StatusUdgivet - jun. 2022


Udforsk hvilke forskningsemner 'Exercise Training as Prophylactic Strategy in the Management of Neutropenia during Chemotherapy' indeholder.